Positive findings with dasotraline for ADHD in children ages 6-12
A new study in children aged 6 to 12 years of dasotraline, a promising new treatment for attention deficit hyperactivity disorder (ADHD), showed significant improvement in efficacy in the treatment of ADHD compared to placebo beginning at week 1 and continuing throughout the study.
Other Articles in this Edition
Sleep program helping ADHD kids rest easier and improve quality of life
Positive findings with dasotraline for ADHD in children ages 6-12
How to Manage Your ADHD While at Work
Why students shouldn’t be forced to spend so much time sitting at desks in class
How are bipolar disorder and ADHD different?
Birth Weight Linked to Mental Health Later in Life
Prescription stimulant misuse, abuse prevalent among adults with ADHD